​

Neurogene Ownership | Who Owns Neurogene?

OverviewForecastRevenueFinancialsChart

Neurogene Ownership Summary

Neurogene is owned by 78.38% institutional investors, 9.28% insiders, and 12.34% retail investors. Physician wealth advisors is the largest institutional shareholder, holding 0% of NGNE shares.

NGNE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeurogene78.38%9.28%12.34%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Physician wealth advisors---
Price t rowe associates inc /md/---
Mariner---
Gsa capital partners llp---
Creative planning---
M&t bank---
Schonfeld strategic advisors---
Squarepoint ops---
Td asset management---
Xtx topco---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Physician wealth advisors---
Price t rowe associates inc /md/---
Mariner---
Gsa capital partners llp---
Creative planning---
M&t bank---
Schonfeld strategic advisors---
Squarepoint ops---
Td asset management---
Xtx topco---

Top Buyers

HolderShares% AssetsChange
Signaturefd---22.00
Physician wealth advisors---29.00
Creative planning---41.00
Bryn mawr trust---132.00
Virtus etf advisers---3.18K

Top Sellers

HolderShares% AssetsChange
Price t rowe associates inc /md/---123.29K
Vestal point capital, lp---80.00K
Squarepoint ops---17.43K
Td asset management---15.80K
Xtx topco---15.26K

Sold Out

HolderChange
Signaturefd-22.00
Physician wealth advisors-29.00
Creative planning-41.00
Bryn mawr trust-132.00
Virtus etf advisers-3.18K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202588-3.30%16,456,9223.74%780.90%45-22.41%2343.75%
Dec 31, 2024928.24%16,089,35716.19%941.42%5831.82%17-22.73%
Sep 30, 20248528.79%13,847,6594.39%811.33%444.76%2257.14%
Jun 30, 20246610.00%13,265,5279.37%781.52%42-2.33%1455.56%
Mar 31, 20246076.47%12,129,50233.19%711.42%4326.47%9-

Recent Insider Transactions

DateNameRoleActivityValue
May 14, 2025Cobb Stuart Chief Scientific OfficerSell$103.00K
Mar 13, 2025Cvijic Christine Mikail President and CFOSell$76.25K
Nov 26, 2024Samsara BioCapital GP, LLC-Buy$406.80K
Nov 26, 2024Samsara BioCapital GP, LLC-Buy$516.83K
Nov 26, 2024Samsara BioCapital GP, LLC-Buy$280.99K

Insider Transactions Trends

DateBuySell
2025 Q2-1
2025 Q1-1
2024 Q46-
2024 Q2--
2024 Q1--

NGNE Ownership FAQ

Who Owns Neurogene?

Neurogene shareholders are primarily institutional investors at 78.38%, followed by 9.28% insiders and 12.34% retail investors. The average institutional ownership in Neurogene's industry, Biotech Stocks , is 63.96%, which Neurogene exceeds.

Who owns the most shares of Neurogene?

Neurogene’s largest shareholders are Physician wealth advisors (0 shares, 0%), Price t rowe associates inc /md/ (0 shares, 0%), and Mariner (0 shares, 0%). Together, they hold 0% of Neurogene’s total shares outstanding.

Does Blackrock own Neurogene?

BlackRock is not among the top 10 institutional shareholders of Neurogene.

Who is Neurogene’s biggest shareholder by percentage of total assets invested?

Physician wealth advisors is Neurogene’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Neurogene shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools